Belfer Research Building
September 9, 2015
(left to right) Mrs. Appel, Dean Glimcher, Dr. Petsko, and Mr. AppelThe annual Symposium began with welcoming remarks by Dr. Laurie H. Glimcher, the Stephen and Suzanne Weiss Dean of Weill Cornell Medical College. Dr. Gregory A. Petsko, the Director of the Helen and Robert Appel Alzheimer's Disease Research Institute, then gave a symposium overview, that was followed by special remarks from Mr. Robert Appel, the Vice Chair of the Board of Overseers.
Dr. Gregory A. PetskoThe presentations, outlined below, highlighted groundbreaking research and discoveries, and the meeting provided a platform for discussing the advances being made in Alzheimer's disease and other related neurodegenerative disorders.
A final panel discussion was then led by Dr. Matthew E. Fink, the Chair of the Department of Neurology.
Dr. David EliezerThe Symposium featured presentations by the following speakers:
Rosa Rademakers, Ph.D.
Consultant and Independent Investigator, Neuroscience Department
Professor of Neuroscience, Mayo Clinic College of Medicine
"Update on the Genetics of Frontotemporal Dementia and Amyotrophic Lateral Sclerosis"
David Eliezer, Ph.D.
Associate Professor of Biochemistry and Neuroscience
Feil Family Brain and Mind Research Institute, Weill Cornell Medical College
"Alpha-synuclein in Parkinson's and Dementia: Rebel without a (Known) Cause"
Jeffrey Sevigny, M.D.
Senior Medical Director, Clinical Development, Biogen Idec
"Aducanumab Development - Preclinical Through POC"
About the Helen and Robert Appel Alzheimer's Disease Research Institute
The Appel Alzheimer's Disease Research Institute at Weill Cornell Medical College, established in 2006, brings together physician-scientists from diverse areas of research with the goal of better understanding the debilitating disease. Through the generosity of Helen and Robert Appel and under the leadership of the Institute's director, Gregory A. Petsko, D.Phil., the Arthur J. Mahon Professor of Neuroscience, our researchers are committed to developing treatments and finding a cure for Alzheimer's disease.